Filana Therapeutics, Inc. (FLNA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 0.74 |
| Open | 0.98 |
| Day High | 1.3 |
| Day Low | 0.9 |
| 52-Week High | 4.98 |
| 52-Week Low | 0.67 |
| Volume | 50.78M |
| Average Volume | 313,744 |
| Market Cap | 49.27M |
| PE | -1.17 |
| EPS | -0.87 |
| Moving Average 50 Days | 0.91 |
| Moving Average 200 Days | 1.61 |
| Change | 0.28 |
Cassava Sciences Announces Name Change to Filana Therapeutics, Inc.
GlobeNewswire Inc.
Mar 10, 2026 12:00 PM GMT
New corporate identity reflects the Company’s mission to develop novel medicines to modulate filamin A and address unmet needs in treating TSC-related epilepsy Filana Therapeutics to begin trading under “FLNA” effective March 11, 2026 AUSTIN, Texas,